ArticleGenome research2026
RECOMBINE identifies recurrent composite markers of cell types and states.
Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Biological function is mediated by the hierarchical organization of cell types and states within tissue ecosystems. Identifying interpretable composite marker sets that both define and distinguish hierarchical cell identities is essential for decoding biological complexity yet remains a major challenge. Here, we present RECOMBINE, an algorithm that identifies recurrent composite marker sets to define hierarchical cell identities. Validation using both simulated and biological data sets demonstrates that RECOMBINE is robust to hyperparameter variation and data sparsity, and achieves higher accuracy in identifying discriminant markers compared with existing approaches. As a partition-free framework, RECOMBINE is particularly powerful for data sets characterized by continuous cell-state transitions, in which defining discrete boundaries is inappropriate. This capability is demonstrated by its application to zebrafish development, revealing gradual transcriptional transitions across embryonic stages, and to the mouse cerebellum, in which it uncovers transcriptional variation shaped by spatial gradients. When applied to single-cell data and validated with spatial transcriptomic data from the mouse visual cortex, RECOMBINE identifies key cell-type markers and generates a robust gene panel for targeted spatial profiling. It also uncovers markers of CD8
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.